DocSym
β
Searchsearch
Search
(Y49.1) Monoamine-oxidase-inhibitor antidepressants
More details coming soon
41 630 in individuals diagnosis monoamine-oxidase-inhibitor antidepressants confirmed
2 424 deaths with diagnosis monoamine-oxidase-inhibitor antidepressants
6% mortality rate associated with the disease monoamine-oxidase-inhibitor antidepressants
Diagnosis monoamine-oxidase-inhibitor antidepressants is diagnosed Women are 41.95% more likely than Men
12 083
Men receive the diagnosis monoamine-oxidase-inhibitor antidepressants
710 (5.9 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
29 547
Women receive the diagnosis monoamine-oxidase-inhibitor antidepressants
1 714 (5.8 %)Died from this diagnosis.
Risk Group for the Disease monoamine-oxidase-inhibitor antidepressants - Men aged 15-19 and Women aged 20-24
In Men diagnosis is most often set at age 5-9, 15-29, 35-54, 65-79
Less common in men the disease occurs at Age 0-5, 10-14, 30-34, 55-64, 80-95+Less common in women the disease occurs at Age 0-5, 80-84, 90-95+
In Women diagnosis is most often set at age 5-79, 85-89
Disease Features monoamine-oxidase-inhibitor antidepressants
Absence or low individual and public risk
Monoamine-oxidase-inhibitor antidepressants - what does this mean
Monoamine-oxidase-inhibitor antidepressants work by blocking the breakdown of certain neurotransmitters, such as serotonin and norepinephrine, which help regulate mood. this results in an increased amount of these neurotransmitters in the brain, allowing them to better regulate mood and reduce symptoms of depression.
What happens during the disease - monoamine-oxidase-inhibitor antidepressants
Monoamine-oxidase-inhibitor antidepressants work by inhibiting the enzyme monoamine-oxidase, which breaks down neurotransmitters such as serotonin, norepinephrine, and dopamine. by blocking the enzyme, these medications increase the levels of these neurotransmitters in the brain, resulting in improved mood and other therapeutic effects.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
10 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Monoamine-oxidase-inhibitor antidepressants - Prevention
Monoamine-oxidase-inhibitor antidepressants can be prevented by avoiding the use of certain medications, such as certain antidepressants and decongestants, that can interact with maois. additionally, it is important to follow the instructions of a physician when taking maois and to monitor for any side effects or adverse reactions.